RNL BIO Co. Ltd., of Germantown, Md., said its scientists collaborated with Samsung Bioscience Research Institute of Samsung Medical Center in Seoul, Korea, on a preclinical study using fat-derived adult stem cells to treat systemic lupus erythematosus (SLE).